P21 Peptide research-grade
P21 Peptide

P21 Peptide

$97.00

Research-grade P21 Peptide for laboratory investigation. For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

P21 Peptide research-grade

Overview

P21 Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for P21 Peptide

Work involving P21 Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of P21 Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source P21 Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with P21 Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using P21 Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of P21 Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 17 PubMed records. Displaying 10 per page.

  1. Bateman RM et al. (2016). 36th International Symposium on Intensive Care and Emergency Medicine: Brussels,… [PMID: 27885969]

    Laboratory literature summary: 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Baazaoui N et al. (2022). Neurodegeneration research models's Disease: Challenges and a investigational… [PMID: 36291618]

    Laboratory literature summary: neurodegeneration research models's Disease: Challenges and a investigational Opportunity to Treat It with a Neurotrophic Compound. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Kazim SF et al. (2016). Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic… [PMID: 27400746]

    Laboratory literature summary: Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging investigational modality for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Lozupone M et al. (2023). The development of peptide- and oligonucleotide-based drugs to prevent the formation… [PMID: 37042028]

    Laboratory literature summary: The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Baazaoui N et al. (2017). Prevention of dendritic and synaptic deficits and cognitive impairment with a… [PMID: 28655344]

    Laboratory literature summary: Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Wei W et al. (2021). Neurotrophic investigation Initiated During Early Postnatal Development Prevents the… [PMID: 34057082]

    Laboratory literature summary: Neurotrophic investigation Initiated During Early Postnatal Development Prevents the neurodegeneration research models-Like Behavior and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Wei W et al. (2020). Prenatal to early postnatal neurotrophic investigation prevents neurodegeneration… [PMID: 32854771]

    Laboratory literature summary: Prenatal to early postnatal neurotrophic investigation prevents neurodegeneration research models-like behavior and pathology in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Bolognin S et al. (2014). Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound [PMID: 24702821]

    Laboratory literature summary: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Mottolese N et al. (2024). Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an… [PMID: 39592934]

    Laboratory literature summary: Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  10. Khatoon S et al. (2015). Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by investigation with a… [PMID: 26401692]

    Laboratory literature summary: Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by investigation with a Neurotrophic Compound. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  11. Baazaoui N et al. (2017). Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and… [PMID: 28387677]

    Laboratory literature summary: Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early investigation with a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Liu Y et al. (2019). Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD… [PMID: 31803044]

    Laboratory literature summary: Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  13. Kazim SF et al. (2014). Disease modifying effect of chronic oral investigation with a neurotrophic peptidergic… [PMID: 25046994]

    Laboratory literature summary: Disease modifying effect of chronic oral investigation with a neurotrophic peptidergic compound in a triple transgenic mouse model of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Falangola MF et al. (2026). Diffusion MRI measures detect brain microstructure changes due to early investigation… [PMID: 41740658]

    Laboratory literature summary: Diffusion MRI measures detect brain microstructure changes due to early investigation with neurotrophic peptide mimetic P021 in the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Falangola MF et al. (2026). Corrigendum to Diffusion MRI measures detect brain microstructure changes due to early… [PMID: 41945082]

    Laboratory literature summary: Corrigendum to Diffusion MRI measures detect brain microstructure changes due to early investigation with neurotrophic peptide mimetic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Kazim SF et al. (2017). Early neurotrophic pharmacotherapy rescues developmental delay and neurodegeneration… [PMID: 28368015]

    Laboratory literature summary: Early neurotrophic pharmacotherapy rescues developmental delay and neurodegeneration research models's-like memory deficits in the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Liu Q et al. (2013). Postnatal development of brain-derived neurotrophic factor (BDNF) and tyrosine protein… [PMID: 22678720]

    Laboratory literature summary: Postnatal development of brain-derived neurotrophic factor (BDNF) and tyrosine protein kinase B (TrkB) receptor immunoreactivity in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size: No selection

5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is P21 peptide?

P21 is a synthetic peptide derived from a sequence associated with neurotrophic activity. It is studied in research laboratories for its role in cellular signaling and neuro-related pathways.

What is P21 used for in research?

P21 is used in research laboratories to investigate neuropeptide signaling, cellular pathway interactions, and receptor-related mechanisms. It is not approved for human use.

Is P21 Peptide approved or intended for human use?

No. P21 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is P21 Peptide FDA-approved for medical or clinical use?

No. P21 is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is P21 supplied?

P21 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should P21 be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for P21?

P21 is available in multiple vial sizes.

Is P21 Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is P21 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments

Can P21 be used for cognitive or health-related purposes?

P21 is studied in research laboratories for neuro-related pathways; however, it is not approved for the diagnosis, experimental regimen, cure, or prevention of any disease or condition.